Mirati Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Mirati Therapeutics, Inc. has filed 798 SEC EDGAR filings since 10 May 2013

SEC filing history

Showing 676-700 of 798 matching filings.

Per page
25
Current page
28
8-K File 001-35921

8-K

Filing date
11 Mar 2015
Reporting date
11 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Mar 2015
Reporting date
09 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Mar 2015
Reporting date
05 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87670

SC 13G/A

Filing date
17 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87670

SCHEDULE 13G AMENDMENT FILING

Filing date
17 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87670

SC 13G/A filing

Filing date
13 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87670

SCHEDULE 13G/A

Filing date
11 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87670

SC 13G/A filing

Filing date
10 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
09 Feb 2015
Reporting date
04 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87670

SC 13G filing

Filing date
09 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2015
Reporting date
04 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2015
Reporting date
04 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2015
Reporting date
04 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2015
Reporting date
04 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2015
Reporting date
04 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Feb 2015
Reporting date
03 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87670

SC 13D/A

Filing date
03 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2015
Reporting date
29 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87670

SC 13D/A

Filing date
02 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Feb 2015
Reporting date
29 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Feb 2015
Reporting date
29 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
29 Jan 2015
Reporting date
28 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-198678

424B5

Filing date
29 Jan 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .